Clinical study and long-term evaluation of immunomodulation therapy on trauma, severe sepsis and multiple organ dysfunction syndrome patients

Chinese Critical Care Medicine

Volumn 18, Issue 11, 2006, Pages 653-656

  Huang, Shun Wei ^a   Guan, Xiang Dong ^a   Chen, Juan ^a   Ou Yang, Bin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Immunomodulation therapy; Multiple organ dysfunction syndrome; Severe sepsis; Trauma

Indexed keywords

CD14 ANTIGEN; HLA DR ANTIGEN; HYPERTENSIVE AGENT; THYMOSIN ALPHA1; ULINASTATIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CRITICAL ILLNESS; FEMALE; FOLLOW UP; HEALTH CARE COST; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; IMMUNOMODULATION; INJURY; INTENSIVE CARE; LENGTH OF STAY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOMODULATION; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROGNOSIS; PROSPECTIVE STUDIES; PROTEASE INHIBITORS; SEPSIS; SINGLE-BLIND METHOD; THYMOSIN; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 37849187601     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. O'Brien J M Jr, Ali N A, Abraham E. Year in review in critical care,2004:sepsis and multi-organ failure[J]. Crit Care,2005,9: 409-413.
2. Hotchkiss R S, Karl I E. The pathophysiology and treatment of sepsis[J]. N Engl J Med,2003,348,138-150.
3. Shoemaker W C, Appel P L, Kram H B. Measurement of tissue perfusion by oxygen transport patterns in experimental shock and in high-risk surgical patients[J]. Intensive Care Med,1990, 16(Suppl 2):S135-144.
4. Bone R C, Balk R A, Cerra F B, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J]. Chest,1992,101:1644-1655.
5. Dellinger R P, Carlet J M, Masur H, et al. Surviving sepsis campaign (SSC) guidelines for management of severe sepsis and septic shock[J]. Crit Care Med,2004,32,858-873.
6. Pugin J. Sepsis and immune response[J]. Intensive Care Med, 1999,25:1027-1028.
7. Perl M, Chung C S, Garber M, et al. Contribution of anti-inflammatory/ immune suppressive processes to the pathology of sepsis[J]. Front Biosci, 2006,11:272-299.
8. Kox W J, Volk T, Kox S N, et al. Immunomodulatory therapies in sepsis[J]. Intensive Care Med,2000,26(Suppl 1):S124-128.
9. Chinese source. 2003,15:135-138.
10. Yamaguchi Y, Ohshiro H, Nagao Y, et al. Urinary trypsin inhibitor reduces C - X - C chemokine production in rat liver ischemia/ reperfusion[J]. J Surg Res,2000,94:107-115.
11. Chinese source. 2004,16,636-638.
12. Oberholzer C, Oberholzer C, Moldawer L L. Sepsis syndromes: understanding the role of innate and acquired immunity[J]. Shock,2001,16:83-96.
13. Weber S U, Schewe J C, Putensen C, et al. Apoptosis as a pathomechanism in sepsis[J]. Anaesthesist,2004,53:59-65.
14. Aosasa S, Ono S, Mochizuki H, et al. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor-alpha production of monocytes[J]. Shock,2001,15:101-105.
15. Kobayashi H, Suzuki M, Tanaka Y, et al. Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C - and MEK/ERK/c - Jun - dependent signaling pathways [J]. J Biol Chem,2001,276:2015-2022.
16. Oberholzer A, Oberholzer C, Minter K M, et al. Considering immunomodulatory therapies in the septic patient: should apoptosis be a potential therapeutic target[J]? Immunol Lett, 2001,75:221-224.
17. Jiang X, Kim H E, Shu H, et al. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway [J]. Science,2003,299:223-226.
18. Chinese source. 2003,2:114-118.
19. Benjamim C F, Hogaboam C M, Kunkel S L. The chronic consequences of severe sepsis [J]. J Leukoc Biol, 2004, 75: 408-412.
20. Slade E, Tamber P S, Vincent J L. The surviving sepsis campaign: raising awareness to reduce mortality [J]. Crit Care, 2003,7:1-2.